Perspectives on strategically managing medication-overuse headache

Medication-overuse headache (MOH) is present in about 2% of the global general population, and results in major disability worldwide. Prof. Rigmor Jensen shares insights into the diagnosis and treatment of MOH at the Danish Headache Center, and highlights the importance of patient education and the impact of COVID-19 on her patients with migraine.